Intravascular large B-cell lymphoma (IVL) is rare and characterized by selective growth of neoplastic cells within the lumina of small blood vessels. We present the case of a 69-year-old woman who died of a widespread IVL with extravascular involvement of the lymph nodes, liver, bladder, and adrenal gland. This report discusses the unique features of IVL with concurrent extravascular components.
I ntravascular large B-cell lymphoma (IVL), also known as angiotrophic lymphoma, was fi rst described in 1959 as an endothelial neoplasm with vascular propagation (1) . Only within the last 15 years has IVL been considered distinctive enough for World Health Organization (WHO) classifi cation (2) . Th e 2008 WHO defi nition states that IVL is a type of extranodal large B-cell lymphoma that selectively grows within the lumina of vessels, particularly capillaries, with the exception of larger arteries and veins. Th e WHO classifi cation also states that this lymphoma is often widely disseminated in extranodal sites, and lymph nodes are usually spared (3). It is also important to note that extravascular infi ltration by tumor cells is observed in only 11% of IVL cases, and patients presenting with classic features of IVL have later developed a nodal diff use large B-cell lymphoma with shared immunophenotypic markers (1) . Th ere are also reports of nodal B-cell lymphoma recurring as IVL (4, 5) and IVL presenting concurrently with a lymphomatous mass in the central nervous system (6) . We report the autopsy fi ndings of a widely disseminated IVL with extensive extravascular involvement by tumor of the lymph nodes, bladder, liver, and adrenal gland.
CASE REPORT
A 69-year-old woman was admitted to Baylor University Medical Center at Dallas with symptoms of fatigue and generalized weakness for the past year, as well as night sweats and fever of 2 weeks' duration. On admission she had a blood pressure of 91/42 mm Hg, a pulse of 140 beats per minute, a temperature of 100.5°F, and oxygen saturation of 95% on room air. Th e clinical diagnosis was probable sepsis. Laboratory studies revealed the following: white blood cell count of 8200/uL (82% segmented neutrophils, 6% normal lymphocytes, 7% monocytes, 4% bands, and 1% metamyelocytes), hemoglobin of 11.4 g/dL, hematocrit of 34.5%, platelet count of 128,000/ uL, sodium of 125 mEq/L, potassium of 4.8 mEq/L, bicarbonate of 17 mEq/L, creatinine of 0.9 mg/dL, glucose of 98 mg/ dL, calcium of 7.4 mg/dL, lactate dehydrogenase of 2070 U/L (normal level: 100-190 U/L), erythrocyte sedimentation rate of 58 mm/h (normal level: 0-30 mm/h), and C-reactive protein of 19.8 mg/dL (normal level: 0-0.3 mg/dL). A chest computed tomography (CT) scan revealed a paratracheal mass, raising clinical suspicion for paraneoplastic syndrome due to lung cancer, and an abdominal CT scan revealed only diverticulosis and abdominopelvic ascites. Despite therapy, she continued with fevers and hypovolemia and developed severe metabolic acidosis (pH 7.12) and acute respiratory failure. She died on the third day after admission.
At necropsy the paratracheal mass seen on imaging proved to be a hematoma contiguous with a central catheter insertion site at the right jugular vein. Th ere was a focal thrombus in the left brachiocephalic vein associated with central catheter placement through the left jugular vein. Grossly within the liver there were numerous tan nodules ranging from 0.2 to 1.8 cm in diameter. Also present was a 1.6 cm tan, fi rm mucosal nodule in the urinary bladder, nodular expansion of the left adrenal gland, and two enlarged periaortic and perinephric lymph nodes. Both lymph nodes were approximately 1.5 cm and fi rm.
Microscopic examination demonstrated atypical lymphoid cells within the lumina of small vessels in most organs and tissues throughout the body, most prominent in the lungs (Figure 1a) . Th ese intravascular lymphoid cells were enlarged with pleomorphic, vesicular nuclei, prominent nucleoli, and multiple mitotic fi gures. Th e thrombus from the left brachiocephalic vein also contained these atypical cells but the paratracheal hematoma did not.
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Cody A. Thomas, MD, Joseph M. Guileyardo, MD, and John R. Krause, MD While most of the tumor was intravascular, there was also signifi cant extravascular tumor infi ltration. Th e bladder, liver, and adrenal gland nodules were dense populations of lymphoma cells (Figure 1b) . Th e enlarged lymph nodes were sclerotic and diff usely involved by intravascular and extravascular lymphoma. Th e bone marrow was 60% to 70% cellular with scattered atypical lymphoid cells present within vascular spaces, but no lymphomatous infi ltration was identifi ed. Immunohistochemical staining revealed that both the intra-and extravascular lymphoma cells of an involved node were CD20 and MUM-1 positive and CD3, CD30, CD15, CD10, BCL6, and Alk-1 negative (Figure 1c) . Th e MUM-1 positivity and the CD10 and BCL6 negativity indicate that this lymphoma was of postgerminal center origin (activated B-cell type). A Ki-67 proliferation index revealed approximately 50% of the tumor cells to be positive.
DISCUSSION
Although 55 years have passed since IVL was fi rst described, our understanding of this entity is still incomplete. Presenting clinical features are usually nonspecifi c and quite variable due to the widespread nature of the disease. Th ere is no laboratory, radiologic, or cytogenetic study specifi c for this diagnosis, and despite being intravascular, peripheral blood involvement is only demonstrated in 5% to 9% of patients (7) . All of these factors commonly delay or prevent antemortem diagnosis. Th e neoplastic cells tend to remain confi ned to small-and intermediate-sized blood vessels with no particular organ preference. Defects in adhesion molecules CD29 (beta 1 integrin), which is essential for leukocyte extravasation, and CD54 (ICAM-1), which is involved in transvascular lymphocyte migration, have been suggested as an explanation for the intravascular localization (8); however, the mechanism is likely multifactorial and more studies are needed.
Th e current case of IVL is unusual because this patient had a prominent, diff use intravascular component of tumor cells associated with a signifi cant extravascular component. Th e morphologic and immunohistochemical characteristics of both components were identical. We believe this aggressive IVL extravasated into the lymph nodes, liver, bladder, and adrenal parenchyma as a diff use large B-cell lymphoma. Nodal lymphoma transformation into intravascular lymphoma (4, 5) is less likely due to the overwhelming intravascular component of lymphoma cells. However, it is not possible to prove the actual temporal sequence without previous biopsies exhibiting the pattern of disease progression. Nevertheless, the distinction can be important since most patients diagnosed with IVL are treated with regimens used for advanced diff use large B-cell lymphoma (7). IVL continues to present diagnostic challenges due to its elusive and diverse pathologic and clinical fi ndings, and according to Ponzoni and colleagues (9) , a comprehensive analysis is needed to fi nd analogies and diff erences between the intravascular and extravascular components of large B-cell lymphomas to further characterize them and potentially formulate more focused treatment depending on each patient's unique presentation.
